These appeals address the issue of territorial jurisdiction in the context of the strict liability for drug-induced death statute, N.J.S.A. 2C:35-9(a), which provides that "[a]ny person who manufactures, distributes or dispenses . . . [a] controlled dangerous substance (CDS) classified in Schedules I or II . . . is strictly liable for a death which results from the injection, inhalation[,] or ingestion of that substance, and is guilty of a crime of the first degree. " New York has no comparable statute. In A-2893-17, the trial court dismissed the strict liability charge against defendants Noel E. Ferguson and Anthony M. Potts, New York residents who allegedly purchased heroin from defendant Shameik Byrd in Paterson and later distributed some of the heroin to the victim in New York, where he died of a heroin overdose. In A-2894-17, the trial court denied Byrd's motion to dismiss the same count of the indictment. The court found that, because Byrd allegedly distributed heroin in New Jersey that ultimately resulted in the user's death, Byrd's conduct fell within the purview of N.J.S.A. 2C:35-9(a). N.J.S.A. 2C:1-3(a)(1) confers territorial jurisdiction in New Jersey when "[e]ither the conduct which is an element of the offense or the result which is such an element occurs within this State." Here, the proofs before the grand jury established that, as to Ferguson and Potts, the distribution and ingestion of heroin and the victim's death all occurred in New York. Accordingly, the State is without territorial jurisdiction to prosecute Ferguson and Potts for strict liability drug-induced death under N.J.S.A. 2C:35-9. The panel concludes there is territorial jurisdiction to prosecute Byrd in New Jersey because his alleged distribution that ultimately resulted in the victim's death occurred in New Jersey, thus satisfying the "conduct" prong of N.J.S.A. 2C:1-3(a)(1). Consequently, the panel affirms the trial court orders.